David Dobrosky

David Dobrosky serves as Chief Business Officer at Transition Bio, Inc.. Transition Bio, Inc. operates in the research sector with approximately 34.0 employees. The company is headquartered in New York, New York. Transition Bio, Inc. generates annual revenue of 2000000.0. To date, Transition Bio, Inc. has raised 108351426.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 WordPress.org Mobile Friendly Google Tag Manager Apache Python

biotechnology research drug discovery condensate technology molecular platform biomolecular condensates oncogenic signaling rna foci molecular screening high throughput screening drug development biophysical assays target validation cell imaging machine learning microfluidics novel therapies binding mechanisms therapeutic hypothesis rare diseases oncology programs ai-based discovery small molecule design biotechnology proteins neurodegenerative diseases target engagement sequestered biomolecules cellular processes disease mechanisms biomaterials serious diseases translational sciences pharmacology indication selection hit identification biophysics protein interactions high-content imaging health challenges biological targets chemistry genomics protein aggregation soft matter physics cellular homeostasis phase screening molecular lens transcriptional assemblies innovative therapeutics artificial intelligence information technology & services

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like David Dobrosky in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Transition Bio, Inc..

David Dobrosky's Position in the MessageCEO Database

• •David Dobrosky is 1 of 1 verified executive contact we track at Transition Bio, Inc..
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •6,778 verified executive contacts in New York are in the database.
• •41 verified contacts work at research companies in the 34.0 employee range (same size as Transition Bio, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach David Dobrosky directly?

David Dobrosky's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Business Officer at Transition Bio, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does David Dobrosky work for?

David Dobrosky is Chief Business Officer at Transition Bio, Inc., a company in the research sector with 34.0 employees. The company is based in New York, New York.

Can I pitch or sell to David Dobrosky?

As Chief Business Officer at Transition Bio, Inc., David Dobrosky is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach David Dobrosky directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is David Dobrosky in?

David Dobrosky works in the research industry as Chief Business Officer at Transition Bio, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is David Dobrosky's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. David Dobrosky's profile is kept up-to-date with the latest available information.

Last updated: June 23, 2026